TR8 PGX Trademark

Trademark Overview

On Wednesday, May 3, 2023, a trademark application was filed for TR8 PGX with the United States Patent and Trademark Office. The USPTO has given the TR8 PGX trademark a serial number of 97918267. The federal status of this trademark filing is REVIVED - AWAITING FURTHER ACTION as of Friday, March 14, 2025. This trademark is owned by Applied DNA Sciences, Inc.. The TR8 PGX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

pharmacogenetic testing services performed for medical treatment and diagnostic purposes
tr8 pgx

General Information

Serial Number97918267
Word MarkTR8 PGX
Filing DateWednesday, May 3, 2023
Status616 - REVIVED - AWAITING FURTHER ACTION
Status DateFriday, March 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkTR EIGHT PGX
Goods and Servicespharmacogenetic testing services performed for medical treatment and diagnostic purposes

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 1, 2023
Primary Code044
First Use Anywhere DateSaturday, April 15, 2023
First Use In Commerce DateSaturday, April 15, 2023

Trademark Owner History

Party NameApplied DNA Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressStony Brook, NY 11790

Trademark Events

Event DateEvent Description
Saturday, May 6, 2023NEW APPLICATION ENTERED
Thursday, June 1, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 30, 2024ASSIGNED TO EXAMINER
Tuesday, January 30, 2024NON-FINAL ACTION WRITTEN
Tuesday, January 30, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 30, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 30, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, April 30, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, July 30, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 30, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 30, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 13, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, August 13, 2024FINAL REFUSAL WRITTEN
Tuesday, August 13, 2024FINAL REFUSAL E-MAILED
Monday, August 26, 2024LETTER OF PROTEST EVIDENCE FORWARDED
Tuesday, August 27, 2024LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Monday, December 2, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, December 2, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, February 3, 2025TEAS PETITION TO REVIVE RECEIVED
Tuesday, March 11, 2025ASSIGNED TO PETITION STAFF
Friday, March 14, 2025NOTICE OF REVIVAL - E-MAILED
Friday, March 14, 2025PETITION GRANTED - RESPONSE RECEIVED

Related Keywords

treatment diagnostic purposes medical performed testing services pharmacogenetic